Martin Shkreli Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Martin Shkreli.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Martin Shkreli. Martin Shkreli is a 10% Owner in KALOBIOS PHARMACEUTICALS INC ($KBIO) and an Chief Executive Officer in KALOBIOS PHARMACEUTICALS INC ($KBIO) and an Chief Executive Officer in Retrophin, Inc. ($RTRX).
Address: 777 THIRD AVENUE, 22ND FLOOR NEW YORK 10017 NY
Companies in which Martin Shkreli is an Insider
HUMANIGEN, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin Shkreli: Chief Executive Officer, 10% Owner
Holdings: 309,723 shares
Current Value: $895,099
Latest Transaction: Aug 29 2016
$KBIO Market Capitalization: $44.71M
$KBIO Previous Close: $2.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin Shkreli: Chief Executive Officer
Holdings: 2,666,246 shares
Current Value: $53,511,557
Latest Transaction: Dec 10 2013
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Martin Shkreli
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29 2016 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Sell | S | 3.10 | 309,723 | 960,141 | 0 | 309.7 K to 0 (-100.00 %) |
| Aug 29 2016 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Sell | S | 3.10 | 1,913,206 | 5,930,939 | 309,723 | 2.2 M to 309.7 K (-86.07 %) |
| Nov 24 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | Chief Executive Off ... | Buy | P | 38.15 | 5,000 | 190,750 | 2,075,200 | 2.1 M to 2.1 M (+0.24 %) |
| Nov 23 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | Chief Executive Off ... | Buy | P | 18.88 | 5,000 | 94,400 | 2,070,200 | 2.1 M to 2.1 M (+0.24 %) |
| Nov 19 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Buy | P | 2.02 | 440,000 | 888,800 | 2,065,200 | 1.6 M to 2.1 M (+27.07 %) |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Buy | P | 2.43 | 7,000 | 17,010 | 1,625,200 | 1.6 M to 1.6 M (+0.43 %) |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Buy | P | 1.93 | 606,677 | 1,170,887 | 1,618,200 | 1 M to 1.6 M (+59.98 %) |